Newsletter | 01 February 2003 Access News 8, Focus on Access Three Years On, February 2003 HIV/AIDS RESEARCH AND DEVELOPMENT TROPICAL & NEGLECTED DISEASES VACCINES The Access Campaign three years on is addressed in this issue of AccessNews, as well as the fear of another meningitis epidemic, Roche's failing of HIV patients, fighting against neglected diseases, no agreements at Doha and HIV positive children. Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechStatementTechnical briefTopic overviewVideo Research article | 29 August 2022 HIV/AIDS Clinical Infectious Diseases: Access to medicines for treating people with cryptococcal meningitis Photograph by Tommy Trenchard Press release Press release | 28 July 2022 HIV/AIDS Following WHO recommendation, access to new game-changing HIV prevention drug needs to be accelerated 4 min Issue brief Issue brief | 25 July 2022 HIV/AIDS Cabotegravir: What are we waiting for? Letter | 19 July 2022 HIV/AIDS CSO letter to ViiV calling for access to HIV PrEP drug CAB-LA Photo credit: Albert Masias/MSF Press release Press release | 20 April 2022 HIV/AIDS MSF responds to new simplified WHO treatment guidelines for cryptococcal meningitis, the number two killer of people living with HIV/AIDS 7 min Photo credit: Njiiri Karago/MSF Press release Press release | 04 March 2022 HIV/AIDS ViiV will not license new game-changing long-acting HIV prevention drug to generic manufacturers 3 min Technical brief | 03 March 2022 HIV/AIDS 20-tool checklist for diagnosing, treating and preventing AIDS Newsletter Newsletter | 01 January 2022 Diabetes HIV/AIDS Tropical & neglected diseases Vaccines Our Wishlist for 2022 Load More
Research article | 29 August 2022 HIV/AIDS Clinical Infectious Diseases: Access to medicines for treating people with cryptococcal meningitis
Photograph by Tommy Trenchard Press release Press release | 28 July 2022 HIV/AIDS Following WHO recommendation, access to new game-changing HIV prevention drug needs to be accelerated 4 min
Photo credit: Albert Masias/MSF Press release Press release | 20 April 2022 HIV/AIDS MSF responds to new simplified WHO treatment guidelines for cryptococcal meningitis, the number two killer of people living with HIV/AIDS 7 min
Photo credit: Njiiri Karago/MSF Press release Press release | 04 March 2022 HIV/AIDS ViiV will not license new game-changing long-acting HIV prevention drug to generic manufacturers 3 min
Technical brief | 03 March 2022 HIV/AIDS 20-tool checklist for diagnosing, treating and preventing AIDS
Newsletter Newsletter | 01 January 2022 Diabetes HIV/AIDS Tropical & neglected diseases Vaccines Our Wishlist for 2022
